Followers | 1076 |
Posts | 80488 |
Boards Moderated | 5 |
Alias Born | 03/10/2009 |
Monday, July 22, 2019 11:14:07 AM
STOP & VISIT MY BOARD AT: HOTTEST PENNY STOCK PICKS
http://investorshub.advfn.com/boards/board.aspx?board_id=19627
My posts are NOT a buy/sell recommendation, Do your Own DD, before you buy any stock - I reserve the right to buy/sell any stock
Recent ALRN News
- Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) • PR Newswire (US) • 09/23/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:06:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 08:06:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:17:00 PM
- Aileron Therapeutics to Present at the 8th Annual IPF Summit • PR Newswire (US) • 08/19/2024 08:05:00 PM
- Aileron Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights • PR Newswire (US) • 08/14/2024 10:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:23:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 09:12:55 PM
- Aileron Therapeutics to Present at the Canaccord Genuity 44th Annual Growth Conference • PR Newswire (US) • 07/30/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:36:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 08:33:11 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/26/2024 08:29:40 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 07/09/2024 12:41:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/09/2024 12:36:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/09/2024 12:30:56 PM
- Aileron Therapeutics to be Included in the Russell Microcap® Index • PR Newswire (US) • 07/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 10:58:30 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/16/2024 09:19:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:01:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 09:16:02 PM
- Aileron Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights • GlobeNewswire Inc. • 05/15/2024 09:13:03 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 09:08:01 PM
- Aileron Therapeutics to Present at Two Upcoming Investor Conferences • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Aileron Therapeutics Announces Closing of Underwritten Registered Direct Offering of up to Approximately $40 Million • GlobeNewswire Inc. • 05/03/2024 08:05:00 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM